PharmaShots Weekly Snapshot (October 14-18, 2019)
1. Johnson & Johnson Initiates Voluntarily Recall of a Single Lot of its Baby Powder in the US
Published: Oct 18, 2019 | Tags: JnJ, Initiates, Voluntarily, Recall, Baby Powder, US
Published: Oct 18, 2019 | Tags: AbbVie, Rinvoq, Upadacitinib, Receives, CHMP, Positive Opinion, Treat, Moderate to Severe Active, Rheumatoid Arthritis
Published: Oct 18, 2019 | Tags: Merck, V920, Ebola Zaire Vaccine, Receives, CHMP, Positive Opinion, Protect, Against, Ebola Virus Disease
4. Cipla to Acquire Venus Remedies’ Elores to Strengthen its Critical Care Footprints in India
Published: Oct 17, 2019 | Tags: Cipla, Acquires, Venus Remedies, Elores, Strengthen, Presence Critical Care, India
5.Amgen and UCB’s Evenity (Romosozumab) Receive CHMP Positive Opinion to Treat Severe Osteoporosis in Postmenopausal Women at High Risk of Fracture
Published: Oct 17, 2019 | Tags: Amgen, UCB, Evenity, Romosozumab, Receive, CHMP, Positive Opinion, Treat, Severe, Osteoporosis, Postmenopausal Women, High Risk of Fracture
Published: Oct 18, 2019 | Tags: Roche, Xofluza, baloxavir marboxil, Receives, US, FDA, Approval, People, Influenza-Related Complications
7. Fitbit Collaborates with BMS-Pfizer Alliance Focusing on Improving Atrial Fibrillation Detection
Published: Oct 17, 2019 | Tags: Fitbit, Collaborates, BMS-Pfizer Alliance, Focusing, Improving, Atrial Fibrillation Detection
Published: Oct 17, 2019 | Tags: UCB, Reports, Results, Bimekizumab, P-III, BE VIVID Study, Moderate to Severe Chronic, Plaque Psoriasis
Published: Oct 16, 2019 | Tags: Ipsen, Signs, Exclusive, Worldwide, License Agreement, Blueprint, Develop, Commercialize, BLU-782, Fibrodysplasia Ossificans Progressiva
Published: Oct 16, 2019 | Tags: Sun Pharma, Launches, Drizalma Sprinkle, duloxetine delayed-release capsules, Neuro-Psychiatric, Pain Disorders, US
Published: Oct 17, 2019 | Tags: AstraZeneca, Daiichi, Report, Acceptance, BLA, US, FDA, Trastuzumab deruxtecan, DS-8201, Priority Review
12. AstraZeneca Collaborates with PetaGene to Deploy PetaSuite in its Core Genomics Initiative
Published: Oct 16, 2019 | Tags: AstraZeneca, Collaborates, PetaGene, Deploy, PetaSuite, Core Genomics Initiative
13. Sandoz Terminates its Prescription Digital Therapies Agreement with Pear Therapeutics
Published: Oct 15, 2019 | Tags: Mitsubishi Tanabe, Signs, License Agreement, Viela Bio, Inebilizumab
14. Lilly Reports Results Pegilodecakin + Folfox in P-III SEQUOIA Study for Metastatic Pancreatic Cancer
Published: Oct 16, 2019 | Tags: Eli Lilly, Reports, Results, Pegilodecakin, Folfox, P-III, SEQUOIA Study, Metastatic Pancreatic Cancer
15. Alexion to Acquire Achillion for ~$930M
Published: Oct 16, 2019 | Tags: Alexion, Acquire, Achillion, ~$930M
16.ProQR’s Sepofarsen Receives FDA’s Rare Pediatric Disease Designation to Treat Leber’s Congenital Amaurosis 10
Published: Oct 15, 2019 | Tags: ProQR, Sepofarsen, Receives, FDA, Rare Pediatric Disease Designation, Leber’s Congenital Amaurosis 10
17.Daiichi Sankyo Acquires Rights for Astellas’ Three Therapies to Boost its Presence in Asia
Published: Oct 15, 2019 | Tags: Daichii Sankyo, Purchases, Astellas, Three Therapies, Boost, Presence, Asia
18. Sanofi and Kaken to Terminate their Co-Marketing Agreement for Clexane by the Year End 2019
Published: Oct 15, 2019 | Tags: Sanofi, Kaken, Terminate, Co-Marketing Agreement, Clexane, 2019
19. Abbott and Tandem Collaborate to Explore Integrated Diabetes Solutions Improving Diabetes Management
Published: Oct 15, 2019 | Tags: Abbott, Tandem, Collaborate, Explore, Integrated Diabetes Solutions, Improving, Diabetes Management
20.Reata Reports Results of Omaveloxolone in P-II MOXIe Registrational Study for Patients with Friedreich’s Ataxia
Published: Oct 15, 2019 | Tags: Reata, Reports, Results, Omaveloxolone, P-II, MOXIe Registrational Study, Patients, Friedreich’s Ataxia
Published: Oct 15, 2019 | Tags: CRISPR Therapeutics, KSQ Therapeutics, Sign, Cross Licensing Agreement, Facilitate, Cell Therapy Programs, Oncology
Published: Oct 14, 2019 | Tags: Kyowa Kirin, Reports, Availability, Nourianz, Istradefylline, Parkinson’s Disease “Off” Episodes, US
Published: Oct 14, 2019 | Tags: Bayer, Janssen, Xarelto, rivaroxaban, Receives, FDA, Approval Prevent, Venous Thromboembolism, Acutely Ill Patients
Published: Oct 14, 2019 | Tags: Abbott, Collaborates, Omada Health, Provide, Integrated Digital Health, Coaching Experience, Patients, Type 2 Diabetes
Published: Oct 15, 2019 | Tags: Takeda, Divest, Select OTC, Non-Core Assets, Acino, Over $200M, NEMEA Countries
Published: Oct 15, 2019 | Tags: Sanofi, Launches, First Digital Manufacturing Facility, Delivering, Next Generation Biologics, Massachusetts
27.Aytu BioScience to Acquire Cerecor’s Prescription Product Portfolio for $17M
Published: Oct 14, 2019 | Tags: Aytu BioScience, Acquire, Cerecor, Prescription Product Portfolio, $17M
28. Exact Sciences and Mayo Clinic Initiate Voyage Study Evaluating the Real-World Impact of Cologuard
Published: Oct 14, 2019 | Tags: Exact Sciences, Mayo Clinic, Initiate, Voyage Study, Evaluating, Real-World Impact, Cologuard
Published: Oct 11, 2019 | Tags: Lilly, Reyvow, lasmiditan, Receives, FDA, Approval, First Therapy, New Class, Acute Treatment Migraine
30. Roche Reports Results of MabThera/Rituxan (rituximab) in P-III PEMPHIX Study for Pemphigus Vulgaris
Published: Oct 14, 2019 | Tags: Roche, Reports, Results, MabThera/Rituxan, rituximab, P-III, PEMPHIX Study, Pemphigus Vulgaris
Published: Oct 14, 2019 | Tags: ImaginAb, Collaborates, Three, Global, Pharmaceutical Companies, Focusing, Development, CD8 ImmunoPET technology